Elmar Kraus
Stock Analyst at DZ BANK AG
(4.08)
# 1,789
Out of 4,662 analysts
152
Total ratings
71.1%
Success rate
10.5%
Average return
Main Sectors:
Stocks Rated by Elmar Kraus
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: 0QIU Novo Nordisk A/S | Maintained: Hold | n/a | $292.75 | - | 14 | Aug 7, 2026 | |
| PFE Pfizer | Maintained: Buy | n/a | $28.24 | - | 10 | Aug 6, 2026 | |
| EPA: SAN Sanofi | Maintained: Buy | n/a | $78.56 | - | 10 | Jul 31, 2026 | |
| LON: GSK GSK plc | Maintained: Hold | n/a | $1,916.00 | - | 10 | Jul 29, 2026 | |
| LON: AZN AstraZeneca PLC | Maintained: Buy | n/a | $12,050.00 | - | 14 | Jul 28, 2026 | |
| LON: 0QW0 argenx SE | Maintained: Buy | n/a | $881.20 | - | 3 | Jul 24, 2026 | |
| SWX: NOVN Novartis AG | Maintained: Hold | n/a | $127.12 | - | 9 | Jul 22, 2026 | |
| SWX: ROP Roche Holding AG | Maintained: Buy | n/a | $367.40 | - | 12 | Feb 2, 2026 | |
| ABBV AbbVie | Downgraded: Hold | $188 → $237 | $265.97 | -10.89% | 4 | Nov 4, 2025 | |
| AMS: PHIA Koninklijke Philips N.V. | Maintained: Hold | n/a | $23.59 | n/a | 7 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $72 → $108 | $147.60 | n/a | 7 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $331 → $343 | $442.36 | n/a | 5 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1,068 → $1,065 | $840.84 | n/a | 3 | May 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $820 → $800 | $1,280.34 | n/a | 6 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $61 → $50 | $67.61 | n/a | 3 | Apr 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $125 → $148 | $152.20 | n/a | 2 | Apr 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $181 → $176 | $273.41 | n/a | 2 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $242 → $236 | $221.56 | n/a | 4 | Feb 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $39 | $23.70 | n/a | 1 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $39.98 | n/a | 20 | Apr 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $52.88 | n/a | 1 | Feb 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $39.52 | n/a | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $90 → $92 | $94.13 | n/a | 2 | May 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $42 | $27.62 | n/a | 1 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $46.48 | n/a | 1 | May 3, 2018 |
Novo Nordisk A/S
Aug 7, 2026
Maintained: Hold
Price Target: n/a
Current: $292.75
Upside: -
Pfizer
Aug 6, 2026
Maintained: Buy
Price Target: n/a
Current: $28.24
Upside: -
Sanofi
Jul 31, 2026
Maintained: Buy
Price Target: n/a
Current: $78.56
Upside: -
GSK plc
Jul 29, 2026
Maintained: Hold
Price Target: n/a
Current: $1,916.00
Upside: -
AstraZeneca PLC
Jul 28, 2026
Maintained: Buy
Price Target: n/a
Current: $12,050.00
Upside: -
argenx SE
Jul 24, 2026
Maintained: Buy
Price Target: n/a
Current: $881.20
Upside: -
Novartis AG
Jul 22, 2026
Maintained: Hold
Price Target: n/a
Current: $127.12
Upside: -
Roche Holding AG
Feb 2, 2026
Maintained: Buy
Price Target: n/a
Current: $367.40
Upside: -
AbbVie
Nov 4, 2025
Downgraded: Hold
Price Target: $188 → $237
Current: $265.97
Upside: -10.89%
Koninklijke Philips N.V.
Jul 29, 2025
Maintained: Hold
Price Target: n/a
Current: $23.59
Upside: n/a
Feb 13, 2025
Upgraded: Buy
Price Target: $72 → $108
Current: $147.60
Upside: n/a
May 7, 2024
Maintained: Buy
Price Target: $331 → $343
Current: $442.36
Upside: n/a
May 6, 2024
Maintained: Buy
Price Target: $1,068 → $1,065
Current: $840.84
Upside: n/a
May 3, 2024
Maintained: Hold
Price Target: $820 → $800
Current: $1,280.34
Upside: n/a
Apr 30, 2024
Maintained: Buy
Price Target: $61 → $50
Current: $67.61
Upside: n/a
Apr 29, 2024
Maintained: Buy
Price Target: $125 → $148
Current: $152.20
Upside: n/a
Apr 18, 2024
Maintained: Buy
Price Target: $181 → $176
Current: $273.41
Upside: n/a
Feb 15, 2024
Maintained: Hold
Price Target: $242 → $236
Current: $221.56
Upside: n/a
Nov 2, 2023
Maintained: Buy
Price Target: $39
Current: $23.70
Upside: n/a
Apr 20, 2022
Maintained: Hold
Price Target: n/a
Current: $39.98
Upside: n/a
Feb 11, 2022
Downgraded: Hold
Price Target: n/a
Current: $52.88
Upside: n/a
Aug 24, 2021
Maintained: Buy
Price Target: n/a
Current: $39.52
Upside: n/a
May 14, 2020
Downgraded: Hold
Price Target: $90 → $92
Current: $94.13
Upside: n/a
Mar 24, 2020
Upgraded: Buy
Price Target: $42
Current: $27.62
Upside: n/a
May 3, 2018
Maintained: Sell
Price Target: n/a
Current: $46.48
Upside: n/a